Monday, August 29, 2016

Epipen Epilogue

Mylan CEO Heather Bresch on Epipen alternative

After the hue and cry last week over accusations of price gouging over EpiPens, the manufacturer Mylan Pharmaceuticals announced that it would begin supplying a generic anti-anaphalaxis medical device that will be half the current $600 price of EpiPens for a two pack.  Mylar noted that the EpiPen brand will also be available for those who are weary of taking generics.

Investors rewarded Mylar at this announcement with a 2% increased valuation in stock. But the public will have lingering suspicions that Heather Bresch sought to inject crony capitalism into EpiPen price gouging

No comments:

Post a Comment